調査レポート | • レポートコード：GIR-2104Z09997 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、NK細胞のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。NK細胞の種類別市場規模（モガムリズマブ、ロルボツズマブメルタンシン、その他）、用途別市場規模（がん、心血管疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・NK細胞の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Chipscreen Biosciences、Affimed NV、Altor BioScience、Innate Pharma、Takeda、Sorrento Therapeutics、NantKwest、Bristol-Myers Squibb、NKT、Henry Ford Health Services、Fortress Biotech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モガムリズマブ、ロルボツズマブメルタンシン、その他 ・用途別分析2016年-2026年：がん、心血管疾患、その他 ・NK細胞の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・NK細胞のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・NK細胞のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・NK細胞の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・NK細胞の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The NK Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global NK Cells size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global NK Cells market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
NK Cells market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market segment by Application can be divided into
Cancer
Cardiovascular Diseases
Others
The key market players for global NK Cells market are listed below:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 NK Cells Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global NK Cells Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global NK Cells Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Global NK Cells Market Size & Forecast
1.4.1 Global NK Cells Sales in Value (2016-2026))
1.4.2 Global NK Cells Sales in Volume (2016-2026)
1.4.3 Global NK Cells Price by Type (2016-2026) & (USD/g)
1.5 Global NK Cells Production Capacity Analysis
1.5.1 Global NK Cells Total Production Capacity (2016-2026)
1.5.2 Global NK Cells Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 NK Cells Market Drivers
1.6.2 NK Cells Market Restraints
1.6.3 NK Cells Trends Analysis
2 Manufacturers Profiles
2.1 Chipscreen Biosciences
2.1.1 Chipscreen Biosciences Details
2.1.2 Chipscreen Biosciences Major Business
2.1.3 Chipscreen Biosciences NK Cells Product and Services
2.1.4 Chipscreen Biosciences NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Affimed NV
2.2.1 Affimed NV Details
2.2.2 Affimed NV Major Business
2.2.3 Affimed NV NK Cells Product and Services
2.2.4 Affimed NV NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Altor BioScience
2.3.1 Altor BioScience Details
2.3.2 Altor BioScience Major Business
2.3.3 Altor BioScience NK Cells Product and Services
2.3.4 Altor BioScience NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Innate Pharma
2.4.1 Innate Pharma Details
2.4.2 Innate Pharma Major Business
2.4.3 Innate Pharma NK Cells Product and Services
2.4.4 Innate Pharma NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda NK Cells Product and Services
2.5.4 Takeda NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sorrento Therapeutics
2.6.1 Sorrento Therapeutics Details
2.6.2 Sorrento Therapeutics Major Business
2.6.3 Sorrento Therapeutics NK Cells Product and Services
2.6.4 Sorrento Therapeutics NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 NantKwest
2.7.1 NantKwest Details
2.7.2 NantKwest Major Business
2.7.3 NantKwest NK Cells Product and Services
2.7.4 NantKwest NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb NK Cells Product and Services
2.8.4 Bristol-Myers Squibb NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 NKT
2.9.1 NKT Details
2.9.2 NKT Major Business
2.9.3 NKT NK Cells Product and Services
2.9.4 NKT NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Henry Ford Health Services
2.10.1 Henry Ford Health Services Details
2.10.2 Henry Ford Health Services Major Business
2.10.3 Henry Ford Health Services NK Cells Product and Services
2.10.4 Henry Ford Health Services NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Fortress Biotech
2.11.1 Fortress Biotech Details
2.11.2 Fortress Biotech Major Business
2.11.3 Fortress Biotech NK Cells Product and Services
2.11.4 Fortress Biotech NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 NK Cells Sales by Manufacturer
3.1 Global NK Cells Sales in Volume by Manufacturer (2019-2021e)
3.2 Global NK Cells Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in NK Cells
3.4 Market Concentration Rate
3.4.1 Top 3 NK Cells Manufacturer Market Share
3.4.2 Top 6 NK Cells Manufacturer Market Share
3.5 Global NK Cells Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and NK Cells Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global NK Cells Market Size by Region
4.1.1 Global NK Cells Sales in Volume by Region (2016-2026)
4.1.2 Global NK Cells Revenue by Region (2016-2026)
4.2 North America NK Cells Revenue (2016-2026)
4.3 Europe NK Cells Revenue (2016-2026)
4.4 Asia-Pacific NK Cells Revenue (2016-2026)
4.5 South America NK Cells Revenue (2016-2026)
4.6 Middle East and Africa NK Cells Revenue (2016-2026)
5 Market Segment by Type
5.1 Global NK Cells Sales in Volume by Type (2016-2026)
5.2 Global NK Cells Revenue by Type (2016-2026)
5.3 Global NK Cells Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global NK Cells Sales in Volume by Application (2016-2026)
6.2 Global NK Cells Revenue by Application (2016-2026)
6.3 Global NK Cells Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America NK Cells Sales by Type (2016-2026)
7.2 North America NK Cells Sales by Application (2016-2026)
7.3 North America NK Cells Market Size by Country
7.3.1 North America NK Cells Sales in Volume by Country (2016-2026)
7.3.2 North America NK Cells Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe NK Cells Sales by Type (2016-2026)
8.2 Europe NK Cells Sales by Application (2016-2026)
8.3 Europe NK Cells Market Size by Country
8.3.1 Europe NK Cells Sales in Volume by Country (2016-2026)
8.3.2 Europe NK Cells Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific NK Cells Sales by Type (2016-2026)
9.2 Asia-Pacific NK Cells Sales by Application (2016-2026)
9.3 Asia-Pacific NK Cells Market Size by Region
9.3.1 Asia-Pacific NK Cells Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific NK Cells Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America NK Cells Sales by Type (2016-2026)
10.2 South America NK Cells Sales by Application (2016-2026)
10.3 South America NK Cells Market Size by Country
10.3.1 South America NK Cells Sales in Volume by Country (2016-2026)
10.3.2 South America NK Cells Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa NK Cells Sales by Type (2016-2026)
11.2 Middle East & Africa NK Cells Sales by Application (2016-2026)
11.3 Middle East & Africa NK Cells Market Size by Country
11.3.1 Middle East & Africa NK Cells Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa NK Cells Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 NK Cells Typical Distributors
12.3 NK Cells Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global NK Cells Revenue by Type, (USD Million), 2021-2026
Table 2. Global NK Cells Revenue by Application, (USD Million), 2021-2026
Table 3. Chipscreen Biosciences Basic Information, Manufacturing Base and Competitors
Table 4. Chipscreen Biosciences Major Business
Table 5. Chipscreen Biosciences NK Cells Product and Services
Table 6. Chipscreen Biosciences NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Affimed NV Basic Information, Manufacturing Base and Competitors
Table 8. Affimed NV Major Business
Table 9. Affimed NV NK Cells Product and Services
Table 10. Affimed NV NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Altor BioScience Basic Information, Manufacturing Base and Competitors
Table 12. Altor BioScience Major Business
Table 13. Altor BioScience NK Cells Product and Services
Table 14. Altor BioScience NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Innate Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Innate Pharma Major Business
Table 17. Innate Pharma NK Cells Product and Services
Table 18. Innate Pharma NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Takeda Basic Information, Manufacturing Base and Competitors
Table 20. Takeda Major Business
Table 21. Takeda NK Cells Product and Services
Table 22. Takeda NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Sorrento Therapeutics Major Business
Table 25. Sorrento Therapeutics NK Cells Product and Services
Table 26. Sorrento Therapeutics NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. NantKwest Basic Information, Manufacturing Base and Competitors
Table 28. NantKwest Major Business
Table 29. NantKwest NK Cells Product and Services
Table 30. NantKwest NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Major Business
Table 33. Bristol-Myers Squibb NK Cells Product and Services
Table 34. Bristol-Myers Squibb NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. NKT Basic Information, Manufacturing Base and Competitors
Table 36. NKT Major Business
Table 37. NKT NK Cells Product and Services
Table 38. NKT NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Henry Ford Health Services Basic Information, Manufacturing Base and Competitors
Table 40. Henry Ford Health Services Major Business
Table 41. Henry Ford Health Services NK Cells Product and Services
Table 42. Henry Ford Health Services NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Fortress Biotech Basic Information, Manufacturing Base and Competitors
Table 44. Fortress Biotech Major Business
Table 45. Fortress Biotech NK Cells Product and Services
Table 46. Fortress Biotech NK Cells Sales (g), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global NK Cells Sales by Manufacturer (2019-2021e) & (g)
Table 48. Global NK Cells Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in NK Cells, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global NK Cells Production Capacity by Company, (g): 2020 VS 2021
Table 51. Head Office and NK Cells Production Site of Key Manufacturer
Table 52. Global NK Cells Sales by Region (2016-2021e) & (g)
Table 53. Global NK Cells Sales by Region (2021-2026) & (g)
Table 54. Global NK Cells Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global NK Cells Revenue by Region (2021-2026) & (USD Million)
Table 56. Global NK Cells Sales by Type (2016-2021e) & (g)
Table 57. Global NK Cells Sales by Type (2021-2026) & (g)
Table 58. Global NK Cells Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global NK Cells Revenue by Type (2021-2026) & (USD Million)
Table 60. Global NK Cells Price by Type (2016-2021e) & (USD/g)
Table 61. Global NK Cells Price by Type (2021-2026) & (USD/g)
Table 62. Global NK Cells Sales by Application (2016-2021e) & (g)
Table 63. Global NK Cells Sales by Application (2021-2026) & (g)
Table 64. Global NK Cells Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global NK Cells Revenue by Application (2021-2026) & (USD Million)
Table 66. Global NK Cells Price by Application (2016-2021e) & (USD/g)
Table 67. Global NK Cells Price by Application (2021-2026) & (USD/g)
Table 68. North America NK Cells Sales by Country (2016-2021e) & (g)
Table 69. North America NK Cells Sales by Country (2021-2026) & (g)
Table 70. North America NK Cells Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America NK Cells Revenue by Country (2021-2026) & (USD Million)
Table 72. North America NK Cells Sales by Type (2016-2021e) & (g)
Table 73. North America NK Cells Sales by Type (2021-2026) & (g)
Table 74. North America NK Cells Sales by Application (2016-2021e) & (g)
Table 75. North America NK Cells Sales by Application (2021-2026) & (g)
Table 76. Europe NK Cells Sales by Country (2016-2021e) & (g)
Table 77. Europe NK Cells Sales by Country (2021-2026) & (g)
Table 78. Europe NK Cells Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe NK Cells Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe NK Cells Sales by Type (2016-2021e) & (g)
Table 81. Europe NK Cells Sales by Type (2021-2026) & (g)
Table 82. Europe NK Cells Sales by Application (2016-2021e) & (g)
Table 83. Europe NK Cells Sales by Application (2021-2026) & (g)
Table 84. Asia-Pacific NK Cells Sales by Region (2016-2021e) & (g)
Table 85. Asia-Pacific NK Cells Sales by Region (2021-2026) & (g)
Table 86. Asia-Pacific NK Cells Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific NK Cells Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific NK Cells Sales by Type (2016-2021e) & (g)
Table 89. Asia-Pacific NK Cells Sales by Type (2021-2026) & (g)
Table 90. Asia-Pacific NK Cells Sales by Application (2016-2021e) & (g)
Table 91. Asia-Pacific NK Cells Sales by Application (2021-2026) & (g)
Table 92. South America NK Cells Sales by Country (2016-2021e) & (g)
Table 93. South America NK Cells Sales by Country (2021-2026) & (g)
Table 94. South America NK Cells Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America NK Cells Revenue by Country (2021-2026) & (USD Million)
Table 96. South America NK Cells Sales by Type (2016-2021e) & (g)
Table 97. South America NK Cells Sales by Type (2021-2026) & (g)
Table 98. South America NK Cells Sales by Application (2016-2021e) & (g)
Table 99. South America NK Cells Sales by Application (2021-2026) & (g)
Table 100. Middle East & Africa NK Cells Sales by Country (2016-2021e) & (g)
Table 101. Middle East & Africa NK Cells Sales by Country (2021-2026) & (g)
Table 102. Middle East & Africa NK Cells Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa NK Cells Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa NK Cells Sales by Type (2016-2021e) & (g)
Table 105. Middle East & Africa NK Cells Sales by Type (2021-2026) & (g)
Table 106. Middle East & Africa NK Cells Sales by Application (2016-2021e) & (g)
Table 107. Middle East & Africa NK Cells Sales by Application (2021-2026) & (g)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. NK Cells Typical Distributors
Table 111. NK Cells Typical Customers
List of Figures
Figure 1. NK Cells Picture
Figure 2. Global NK Cells Sales Market Share by Type in 2020
Figure 3. Mogamulizumab
Figure 4. Lorvotuzumab Mertansine
Figure 5. Others
Figure 6. Global NK Cells Sales Market Share by Application in 2020
Figure 7. Cancer
Figure 8. Cardiovascular Diseases
Figure 9. Others
Figure 10. Global NK Cells Market Size, (USD Million) & (g): 2020 VS 2021 VS 2026
Figure 11. Global NK Cells Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey NK Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global NK Cells Sales (2016-2026) & (g)
Figure 32. Global NK Cells Production Capacity (2016-2026) & (g)
Figure 33. Global NK Cells Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. NK Cells Market Drivers
Figure 35. NK Cells Market Restraints
Figure 36. NK Cells Market Trends
Figure 37. Global NK Cells Sales Market Share by Manufacturer in 2020
Figure 38. Global NK Cells Revenue Market Share by Manufacturer in 2020
Figure 39. NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 NK Cells Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 NK Cells Manufacturer (Revenue) Market Share in 2020
Figure 42. Global NK Cells Sales Market Share by Region (2016-2026)
Figure 43. Global NK Cells Revenue Market Share by Region (2016-2026)
Figure 44. North America NK Cells Revenue (2016-2026) & (USD Million)
Figure 45. Europe NK Cells Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific NK Cells Revenue (2016-2026) & (USD Million)
Figure 47. South America NK Cells Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa NK Cells Revenue (2016-2026) & (USD Million)
Figure 49. Global NK Cells Sales Market Share by Type (2016-2026)
Figure 50. Global NK Cells Revenue Market Share by Type (2016-2026)
Figure 51. Global NK Cells Price by Type (2016-2026) & (USD/g)
Figure 52. Global NK Cells Sales Market Share by Application (2016-2026)
Figure 53. Global NK Cells Revenue Market Share by Application (2016-2026)
Figure 54. Global NK Cells Price by Application (2016-2026) & (USD/g)
Figure 55. North America NK Cells Sales Market Share by Country (2016-2026)
Figure 56. North America NK Cells Revenue Market Share by Country (2016-2026)
Figure 57. North America NK Cells Sales Market Share by Type (2016-2026)
Figure 58. North America NK Cells Sales Market Share by Application (2016-2026)
Figure 59. Europe NK Cells Sales Market Share by Country (2016-2026)
Figure 60. Europe NK Cells Revenue Market Share by Country (2016-2026)
Figure 61. Europe NK Cells Sales Market Share by Type (2016-2026)
Figure 62. Europe NK Cells Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific NK Cells Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific NK Cells Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific NK Cells Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific NK Cells Sales Market Share by Application (2016-2026)
Figure 67. South America NK Cells Sales Market Share by Country (2016-2026)
Figure 68. South America NK Cells Revenue Market Share by Country (2016-2026)
Figure 69. South America NK Cells Sales Market Share by Type (2016-2026)
Figure 70. South America NK Cells Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa NK Cells Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa NK Cells Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa NK Cells Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa NK Cells Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のKセル市場 2021：企業別、地域別、種類・用途別 The K Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent dev…- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 世界のがん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. Over the past few years, stem cells are being successf…
- 世界の微生物燃料電池（MFC）市場規模・現状・予測（2021年-2027年） Microbial Fuel Cell (MFC) is a bio-electrochemical system that produces electric current by using bacteria. MFC is essentially a device that converts chemical energy into electrical energy by using bacteria or microorganisms. MFC has gained attention due to its capability to produce electricity from…
- 世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…